{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:02:44Z","timestamp":1790686964206,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T00:00:00Z","timestamp":1501027200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005869","name":"University of Fribourg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005869","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10096-017-3063-z","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T16:47:32Z","timestamp":1501087652000},"page":"2319-2327","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["Activity of the novel siderophore cephalosporin cefiderocol against multidrug-resistant Gram-negative pathogens"],"prefix":"10.1007","volume":"36","author":[{"given":"J.","family":"Dobias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"D\u00e9nervaud-Tendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Poirel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nordmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,26]]},"reference":[{"issue":"3","key":"3063_CR1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JDD Pitout","year":"2008","unstructured":"Pitout JDD, Laupland KB (2008) Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8(3):159\u2013166","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"3063_CR2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF01641355","volume":"11","author":"H Knothe","year":"1983","unstructured":"Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 11(6):315\u2013317","journal-title":"Infection"},{"issue":"8","key":"3063_CR3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/AAC.33.8.1131","volume":"33","author":"A Philippon","year":"1989","unstructured":"Philippon A, Labia R, Jacoby G (1989) Extended-spectrum \u03b2-lactamases. Antimicrob Agents Chemother 33(8):1131\u20131136","journal-title":"Antimicrob Agents Chemother"},{"key":"3063_CR4","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1086\/344654","volume":"36","author":"DM Livermore","year":"2003","unstructured":"Livermore DM (2003) Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36:S11\u2013S23","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3063_CR5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/cid\/cir202","volume":"53","author":"N Gupta","year":"2011","unstructured":"Gupta N, Limbago BM, Patel JB, Kallen AJ (2011) Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53(1):60\u201367","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3063_CR6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.4065\/mcp.2010.0674","volume":"86","author":"SS Kanj","year":"2011","unstructured":"Kanj SS, Kanafani ZA (2011) Current concepts in antimicrobial therapy against resistant gram-negative organisms: extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa. Mayo Clin Proc 86(3):250\u2013259","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"3063_CR7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(16)00006-2","volume":"16","author":"L Poirel","year":"2016","unstructured":"Poirel L, Kieffer N, Liassine N, Thanh D, Nordmann P (2016) Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. Lancet Infect Dis 16(3):281","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"3063_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(15)00424-7","volume":"16","author":"YY Liu","year":"2016","unstructured":"Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J (2016) Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16(2):161\u2013168","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"3063_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(16)00007-4","volume":"16","author":"M Haenni","year":"2016","unstructured":"Haenni M, Poirel L, Kieffer N, Ch\u00e2tre P, Saras E, M\u00e9tayer V, Dumoulin R, Nordmann P, Madec JY (2016) Co-occurrence of extended spectrum \u03b2 lactamase and MCR-1 encoding genes on plasmids. Lancet Infect Dis 16(3):281\u2013282","journal-title":"Lancet Infect Dis"},{"key":"3063_CR10","doi-asserted-by":"crossref","unstructured":"Hasman H, Hammerum AM, Hansen F, Hendriksen RS, Olesen B, Agers\u00f8 Y, Zankari E, Leekitcharoenphon P, Stegger M, Kaas RS, Cavaco LM, Hansen DS, Aarestrup FM, Skov RL (2015) Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill 20(49)","DOI":"10.2807\/1560-7917.ES.2015.20.49.30085"},{"issue":"2","key":"3063_CR11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/AAC.01695-15","volume":"60","author":"N Kohira","year":"2015","unstructured":"Kohira N, West J, Ito A, Ito-Horiyama T, Nakamura R, Sato T, Rittenhouse S, Tsuji M, Yamano Y (2015) In vitro antimicrobial activity of a siderophore cephalosporin, S-649266, against Enterobacteriaceae clinical isolates, including carbapenem-resistant strains. Antimicrob Agents Chemother 60(2):729\u2013734","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3063_CR12","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1128\/AAC.01405-16","volume":"60","author":"A Ito","year":"2016","unstructured":"Ito A, Nishikawa T, Matsumoto S, Yoshizawa H, Sato T, Nakamura R, Tsuji M, Yamano Y (2016) Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother 60(12):7396\u20137401","journal-title":"Antimicrob Agents Chemother"},{"key":"3063_CR13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4137\/IDRT.S31567","volume":"9","author":"GS Tillotson","year":"2016","unstructured":"Tillotson GS (2016) Trojan horse antibiotics\u2014a novel way to circumvent gram-negative bacterial resistance? Infect Dis (Auckl) 9:45\u201352","journal-title":"Infect Dis (Auckl)"},{"issue":"7","key":"3063_CR14","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/AAC.03098-15","volume":"60","author":"T Ito-Horiyama","year":"2016","unstructured":"Ito-Horiyama T, Ishii Y, Ito A, Sato T, Nakamura R, Fukuhara N, Tsuji M, Yamano Y, Yamaguchi K, Tateda K (2016) Stability of novel siderophore cephalosporin S-649266 against clinically relevant carbapenemases. Antimicrob Agents Chemother 60(7):4384\u20134386","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"3063_CR15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jac\/dkv402","volume":"71","author":"A Ito","year":"2016","unstructured":"Ito A, Kohira N, Bouchillon SK, West J, Rittenhouse S, Sader HS, Rhomberg PR, Jones RN, Yoshizawa H, Nakamura R, Tsuji M, Yamano Y (2016) In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting gram-negative bacteria. J Antimicrob Chemother 71(3):670\u2013677","journal-title":"J Antimicrob Chemother"},{"key":"3063_CR16","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2015) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standards\u2014tenth edition. CLSI document M07-A10. CLSI, Wayne, PA"},{"issue":"2","key":"3063_CR17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diagmicrobio.2017.03.011","volume":"88","author":"MD Huband","year":"2017","unstructured":"Huband MD, Ito A, Tsuji M, Sader HS, Fedler KA, Flamm RK (2017) Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller\u2013Hinton broth using a CLSI M23-A4 multi-laboratory study design. Diagn Microbiol Infect Dis 88(2):198\u2013200","journal-title":"Diagn Microbiol Infect Dis"},{"key":"3063_CR18","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2015) Performance standards for antimicrobial susceptibility testing; Twenty-fifth informational supplement. CLSI document M100-S25. CLSI, Wayne, PA"},{"key":"3063_CR19","doi-asserted-by":"crossref","unstructured":"Katsube T, Wajima T, Ishibashi T, Camilo Arjona Ferreira J, Echols R (2017) Pharmacokinetic\/pharmacodynamic modeling and simulation of cefiderocol, a parenteral siderophore cephalosporin, for dose adjustment based on renal function. Antimicrob Agents Chemother 61(1). pii: e01381-16","DOI":"10.1128\/AAC.01381-16"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-3063-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-3063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T10:21:19Z","timestamp":1659262879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-3063-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,26]]},"references-count":19,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3063"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-3063-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727846566.793555358","asserted-by":"object"}]},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,26]]}}}